CIFoundry
Back to Catalog
Oncology
FDA Cleared

ArteraAI Breast

Save to shortlist
Artera

Last reviewed Oct 31, 2026 against the sources listed on this page · How we review

At a glance

ArteraAI Breast is an AI tool that analyzes digitized H&E pathology slides from breast cancer biopsies to give prognostic risk information that supports treatment decisions.

FDA:
510(k) K254115 +1 more
Epic:
Not on record
Named users:
Not on record
Published study:
Not on record

Description

ArteraAI Breast is an AI tool that analyzes digitized H&E pathology slides from breast cancer biopsies to give prognostic risk information that supports treatment decisions. It received FDA 510(k) clearance K254115 in May 2026.

FDA 510(k)digital pathologybreast canceroncology

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is ArteraAI Breast FDA cleared?
The public FDA database has 2 records that our team matched to ArteraAI Breast. The most recent is 510(k) K254115 (ArteraAI Breast), decided May 2026. Check that the cleared use matches how you plan to use it.FDA record K254115

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Regulatory submission summary

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

No public deployments found yet (checked Oct 2026). Using this tool? The maker can claim the listing to add customers.

Get weekly updates for Oncology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website FDA Record

FDA database records

  • K254115 · 510(k) · May 2026
    ArteraAI Breast
  • DEN240068 · De Novo · Jul 2025
    ArteraAI Prostate

Matched by our team from the public FDA database; checked Nov 10, 2026.

History (3)Show

Dated events on this listing's public record, newest first.

  1. Sep 27, 2026

    Added to CIFoundry

  2. May 4, 2026

    FDA 510(k) K254115 decision datesource

  3. Jul 31, 2025

    FDA De Novo DEN240068 decision datesource

Developer

Artera

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.